Zogenix reported $21.32M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
AstraZeneca AZN:LN 6.04B 15M
Becton, Dickinson and BDX:US $ 2254M 93M
Biocryst Pharmaceuticals BCRX:US $ 40.38M 9.24M
Biogen BIIB:US $ 2267.1M 48.2M
Cardinal Health CAH:US 1.64B 167M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Flexion Therapeutics FLXN:US $ 17.6M 5.6M
GlaxoSmithKline GSK:LN 6.26B 682M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Intra Cellular Therapies ITCI:US $ 20.21M 2.2M
Johnson & Johnson JNJ:US $ 16088M 343M
Merk MRK:US $ 10098M 1738M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Pfizer PFE:US $ 14163M 2178M
Revance Therapeutics RVNC:US $ 13.86M 481K
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Zogenix ZGNX:US $ 21.32M 3.75M